Inverna Therapeutics
PrivateLast Round
Grant
Oct 9, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inverna Therapeutics is a biotechnology company that is a developer of a next-generation ribonucleic acid splicing modulation platform intended to transform patient outcomes in severe genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inverna Therapeutics Comparables
Compare Inverna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harness Therapeutics | 79% | |
| Vico | 76% | |
| Skyhawk Therapeutics | 73% |
Inverna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 9, 2025 | ||||
| Seed | Jan 7, 2025 |
Key People
Founding team and executive leadership
Inverna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Southern Denmark | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 509% MoM, from 157 to 956.
- Apr 17, 2026
Monthly visitors increased 139% MoM.
Inverna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inverna Therapeutics's valuation, stock price, and market status.
Is Inverna Therapeutics a public or private company?
Inverna Therapeutics is a private company.
What is the current stock price of Inverna Therapeutics?
Inverna Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Inverna Therapeutics worth (valuation)?
Valuation information for Inverna Therapeutics is not publicly available.
Can I buy Inverna Therapeutics stock?
Inverna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inverna Therapeutics's last funding round?
Inverna Therapeutics's most recent funding round was Grant on October 9, 2025.
Who are the main investors in Inverna Therapeutics?
Key investors in Inverna Therapeutics include University of Southern Denmark, The Michael J. Fox Foundation for Parkinson's Research.
Will Inverna Therapeutics IPO soon?
No public IPO plans have been announced for Inverna Therapeutics.
How can I track Inverna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inverna Therapeutics's secondary market activity and sign up for updates.